$SLS You just don't want to go into your first R&D Investorsday announcing stellar results with a shareprice around $.20. Hence the RS which was schedueled for months. Ignorant retail buying into a healed BC ghoststory however didn't make an informed decision buying on Tuesday. And they made an equally ignorant and silly decision selling yesterday imo. Fundamentals and upcoming catalysts remain untouched. Do your own DD.